2024    2023    2022    2021    2020    2019    2018    2017    2016   


   
   


   

Return to the full list of publications for the current year


Check our Open Access Repository.

2022


79 publication(s):

Note: when necessary, only the first 15 authors are displayed.

International refereed journal articles

1 - 
Periosteal Skeletal Stem Cells Can Migrate into the Bone Marrow and Support Hematopoietic Regeneration
Kemi Akinnola, Tony Marchand, Shoichiro Takeishi, Maria Marianovich, Sandra Pinho, Thierry Lamy, Karin Tarte, Julien Saint-Vanne, Paul S Frenette, Kira Gritsman
Blood, 2022, 140 (Supplement 1), pp.8629-8630.
DOI : https://doi.org/10.1182/blood-2022-169579
 Reprint request: Subject to availability
2 - 
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
Emmanuel Bachy, Roch Houot, Pierre Feugier, Krimo Bouabdallah, Reda Bouabdallah, Emmanuelle Nicolas Virelizier, Marie Maerevoet, Christophe Fruchart, Sylvia Snauwaert, Steven Le Gouill, Jean-Pierre Marolleau, Lysiane Molina, Cecile Molucon-Chabrot, Catherine Thieblemont, Herve Tilly et al.
Blood, 2022, 139 (15), pp.2338-2346.
DOI : https://doi.org/10.1182/blood.2021013526
Pubmed : 34936697
PDF file
 Reprint request: Subject to availability
3 - 
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study
Soraya Benguerfi, Thierry Lesimple, Roch Houot, Charles Ricordel, Delphine Legoupil, Corinne Alleaume, Regine Lamy, Delphine Deniel Lagadec, Romain Corre
Acta Oncologica, 2022, 61 (11), pp.1339-1346.
DOI : https://doi.org/10.1080/0284186X.2022.2132114
Pubmed : 36239950
 Reprint request: Subject to availability
4 - 
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition
Amina Bensalem, Guillaume Cartron, Ulrich Specks, Denis Mulleman, Emmanuel Gyan, Divi Cornec, Celine Desvignes, Olivier Casasnovas, Thierry Lamy, Stéphane Leprêtre, Gilles Paintaud, David Ternant
Clinical Pharmacokinetics, 2022, 61 (3), pp.423-437.
DOI : https://doi.org/10.1007/s40262-021-01081-3
Pubmed : 34773607
 Reprint request: Subject to availability
5 - 
Invited Response on: Comment on "Lipo-Body Lift Reconstruction Following Massive Weight Loss-Our Experience with 100 Consecutive Cases"
Yanis Berkane, Alexis P Arnaud, Silvia Gandolfi, Nicolas Bertheuil
Aesthetic Plastic Surgery, 2022, 46 (1), pp.579-580.
DOI : https://doi.org/10.1007/s00266-021-02316-1
Pubmed : 34041555
 Reprint request: Subject to availability
6 - 
Comment on "Augmentation mammaplasty by superolateral thoracic flap: a case report"
Yanis Berkane, Nicolas Bertheuil
Journal of Medical Case Reports, 2022, 16 (1),
DOI : https://doi.org/10.1186/s13256-022-03602-5
Pubmed : 36253835
PDF file
 Reprint request: Subject to availability
7 - 
In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial
Nicolas Boissel, Francoise Huguet, Thibaut Leguay, Hunault-Berger Mathilde, Carlos Graux, Yves Chalandon, Eric Delabesse, Yosr Hicheri, Patrice Chevallier, Marie Balsat, Cedric Pastoret, Martine Escoffre-Barbe, Florence Pasquier, Jean-Pierre Marolleau, Anne Thiebaut-Bertrand et al.
Blood, 2022, 140 (Supplement 1), pp.112-114.
DOI : https://doi.org/10.1182/blood-2022-157903
 Reprint request: Subject to availability
8 - 
Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B Study
Nicolas Boissel, Francoise Huguet, Thibaut Leguay, Mathilde Hunault, Rathana Kim, Yosr Hicheri, Patrice Chevallier, Marie Balsat, Sébastien Maury, Anne Thiebaut-Bertrand, Florence van Obbergh, Thomas Cluzeau, Martine Escoffre-Barbe, Nicole Straetmans, Johanna Konopacki et al.
Blood, 2022, 140 (Supplement 1), pp.507-509.
DOI : https://doi.org/10.1182/blood-2022-159397
 Reprint request: Subject to availability
9 - 
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study
Antoine Bonnet, Céline Bossard, Ludovic Gabellier, Julien Rohmer, Othman Laghmari, Marie Parrens, Clementine Sarkozy, Remy Dulery, Virginie Roland, Francisco Llamas-Gutierrez, Lucie Oberic, Luc-Matthieu Fornecker, Laura Bounaix, Bruno Villemagne, Vanessa Szablewski et al.
Cancer Medicine, 2022, 11 (19), pp.3602-3611.
DOI : https://doi.org/10.1002/cam4.4742
Pubmed : 35538643
PDF file
 Reprint request: Subject to availability
10 - 
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
Christophe Bonnet, Jehan Dupuis, Hervé Tilly, Thierry Lamy, Christophe Fruchart, Steven Le Gouill, Catherine Thieblemont, Franck Morschhauser, Olivier Casasnovas, Krimo Bouabdallah, Herve Ghesquieres, Eric van den Neste, Marc Andre, Guillaume Cartron, Gilles Salles et al.
Cancers, 2022, 14 (7), pp.1761.
DOI : https://doi.org/10.3390/cancers14071761
Pubmed : 35406532
PDF file
 Reprint request: Subject to availability


Export data displayed in CSV Export data displayed in RTF